ARCHIVES

Gottlieb questions ODAC’s independence.

This article is from The Cancer Letter archive.

Vol. 31 No. 31 | August 5, 2005

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Approved By NCI CTEP During May

June 28, 2002

Guest Editorial: The Academic Difference: George Weiner On How America’s Cancer Centers Are More Valuable Than Ever

October 31, 2014

Promising Results For Glivec In CML Continue, FDA Grants Priority Review

April 27, 2001

In Brief: Wittes to Join Bristol-Myers As VP; Friedman Named Acting CTEP Director; Carl Pinsky Leaves

September 23, 1988

List Of NCI Divisions, Addresses And Telephone Numbers

October 13, 1995

Budesonide Not Beneficial For Diarrhea In Melanoma

August 28, 2009